Nuclear pore associated protein 1 pseudogene 2 (NPAP1P2)

Nuclear pore associated protein 1 pseudogene 2 (NPAP1P2) is a pseudogene—a DNA sequence similar to the functional NPAP1 gene but incapable of producing a functional protein product[5]. NPAP1P2 is not classified as a therapeutic target, receptor, enzyme, transporter, or member of any other pharmacologically relevant molecular family. Pseudogenes like NPAP1P2 may sometimes participate in gene regulation, acting as microRNA sponges or influencing mRNA stability, but there is no specific literature describing such a functional role for NPAP1P2[2][8]. The NPAP1 gene (its ancestor) is involved in brain function and has been linked to Prader-Willi syndrome and Angelman syndrome through parental imprinting mechanisms, but NPAP1P2 lacks evidence of functional or disease relevance[3][1]. Naming conventions for pseudogenes follow HGNC/HUGO guidelines, requiring the “P” and a number appended to the functional parent gene’s symbol[5]. The consensus in current nomenclature and genomics resources is that NPAP1P2 is a processed pseudogene, not an active coding gene. No aliases, interacting drugs, or safety concerns are documented. Nuclear pore associated protein 1 pseudogene 2 (NPAP1P2) is a non-coding pseudogene with sequence homology to nuclear pore associated protein 1 (NPAP1). It lacks known protein product, biological function, or clinical relevance as a therapeutic target. It is not considered a molecular target for drug action or disease intervention.

None